| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |